Physician profile
Adel D Irani
NPI 1912093113
$1,358.07
in general payments reported to CMS, 2019-2025
17 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $187 · 2021: $275 · 2022: $192 · 2023: $98.27 · 2024: $169 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $382.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $408.72 | 2019-2022 | |
| Ethicon US, LLC | $228.61 | 2019-2023 | Prolene, Stratafix, Evarrest |
| Abiomed | $149.14 | 2021 | |
| Abbott Laboratories | $114.62 | 2025 | Epic |
| Lexington Medical, INC. | $79.57 | 2024 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Atricure, INC. | $56.57 | 2024 | |
| Tetraphase Pharmaceuticals, INC. | $46.04 | 2019 | |
| Shire North American Group INC | $40.22 | 2019 | |
| Davol INC. | $38.74 | 2019 | |
| W. L. Gore & Associates, INC. | $38.21 | 2021 | |
| Janssen Pharmaceuticals, INC | $35.90 | 2019 | |
| Acell, INC. | $35.76 | 2019 | |
| Covidien LP | $20.19 | 2019 | |
| Pfizer INC. | $18.70 | 2019 | |
| Integra Lifesciences Corporation | $17.09 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $16.04 | 2024 | Oasis, Stravix |
| Baxter Healthcare | $13.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adel Irani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.